Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2026 Earnings Call Transcript May 14, 2026
Karyopharm Therapeutics Inc. beats earnings expectations. Reported EPS is $-1.24, expectations were $-1.45.
Operator: Good morning, everybody. My name is Kelsy, and I will be your conference operator for today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics First Quarter 2026 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be...
